SJS Investment Consulting
SLS icon

SJS Investment Consulting’s SELLAS Life Sciences SLS Stock Holding History

SJS Investment Consulting’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$492K Hold
40,000
– – 0.05% 95
2026
Q2 		$590K Buy
40,000
+15,000
+60% +$104K 0.06% 83
2026
Q1 		$106K Buy
+25,000
New +$112K 0.01% 210

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return
Vision Financial Markets
Vision Financial Markets Stamford, Connecticut $131M AUM 8.71% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Instrumental Wealth
Instrumental Wealth Tampa, Florida $206M AUM 16.83% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $553M AUM 22.48% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
Visionary Horizons
Visionary Horizons Knoxville, Tennessee $251M AUM 14.92% 1-Year Est. Return

SJS Investment Consulting's SLS Position: Q3 2026 in Review

SJS Investment Consulting held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 40,000 shares worth $492K. The position accounts for 0.05% of the portfolio, ranked #95.

SJS Investment Consulting first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $590K in Q2 2026. 41 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • SJS Investment Consulting held 40,000 shares of SELLAS Life Sciences worth $492K as of Q3 2026.
  • SJS Investment Consulting left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up 0.05% of SJS Investment Consulting's portfolio in Q3 2026, its #95 holding.
  • SJS Investment Consulting first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • SJS Investment Consulting's SELLAS Life Sciences position peaked at $590K in Q2 2026.
  • 41 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.